195 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

TGTX

TG Therapeutics
US$23.33-7.7%166.0%US$3.3bUS$33.75PE35xE43.5%n/a

CORT

Corcept Therapeutics
US$43.285.8%31.2%US$4.4bUS$65.40PE36.2xE38.4%n/a

AVTR

Avantor
US$26.06-5.9%25.3%US$17.5bUS$28.57PE49.2xE25.0%n/a

HALO

Halozyme Therapeutics
US$56.95-4.3%45.5%US$7.1bUS$61.10PE21.4xE22.0%n/a

AZN

AstraZeneca
UK£117.20-1.5%6.5%UK£181.7bUK£138.09PE37.8xE16.4%1.9%

603456

Zhejiang Jiuzhou Pharmaceutical
CN¥13.477.1%-53.5%CN¥12.1bCN¥18.40PE13.7xE17.4%3.7%

524348

Aarti Drugs
₹517.55-0.2%-4.4%₹47.6b₹536.00PE30.3xE36.4%0.2%

KRKG

Krka d. d
€137.000.7%25.1%€4.2b€133.10PE11.5xE3.7%5.5%

A001060

JW Pharmaceutical
₩29,150.006.6%-22.4%₩718.8b₩41,500.00PE20.6xE29.4%1.3%

688687

Beijing Kawin Technology Share-Holding
CN¥22.1813.2%-8.9%CN¥3.7bCN¥35.56PE30.8xE30.3%1.1%

688566

Jiangsu Jibeier Pharmaceutical
CN¥20.848.5%-31.1%CN¥4.2bn/aPE17xE21.3%2.5%

ORCHPHARMA

Orchid Pharma
₹1,371.250.7%159.7%₹69.5b₹1,525.33PE62xE43.7%n/a

300357

Zhejiang Wolwo Bio-Pharmaceutical
CN¥18.659.6%-37.3%CN¥9.8bCN¥29.46PE31.4xE23.8%1.0%

GXI

Gerresheimer
€96.90-4.8%-3.1%€3.3b€131.12PE29xE22.2%1.3%

BSEM

BioStem Technologies
US$10.353.1%305.9%US$171.6mUS$24.25PE20.8xS48.8%n/a

300653

Yantai Zhenghai Biotechnology
CN¥19.764.9%-38.2%CN¥3.5bCN¥30.12PE21.2xE22.1%4.1%

APLLTD

Alembic Pharmaceuticals
₹1,195.754.4%56.7%₹235.0b₹1,066.33PE37.3xE18.6%0.9%

4530

Hisamitsu Pharmaceutical
JP¥4,011.001.6%-26.1%JP¥294.2bJP¥4,350.00PE20xE9.9%2.1%

600201

Jinyu Bio-technology
CN¥6.439.7%-31.7%CN¥7.2bCN¥7.94PE26.4xE27.6%1.2%

IBNSINA

IBN SINA Pharmaceutical Industry
৳362.903.6%26.6%৳11.5b৳390.00PE16.4xE19.2%1.7%

GTII

Green Thumb Industries
CA$14.010.6%-6.4%CA$3.3bCA$25.85PE37.5xE29.5%n/a

SLV

Selvita
zł56.80-11.8%-4.9%zł1.0bzł69.65PE22xE24.5%n/a

BRKR

Bruker
US$70.443.2%12.8%US$10.2bUS$79.74PE30.3xE20.8%0.3%

600572

Zhejiang CONBA PharmaceuticalLtd
CN¥4.398.4%-22.3%CN¥11.0bCN¥7.27PE24.1xE25.3%4.6%
Page 5 of 9
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.